NCT02574351

Brief Summary

To study whether the immune response as directed by regulatory T cells is different between obese asthmatics, normal weight asthmatics and healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

November 1, 2013

Completed
1.9 years until next milestone

First Posted

Study publicly available on registry

October 12, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

January 29, 2016

Status Verified

January 1, 2016

Enrollment Period

4.6 years

First QC Date

November 1, 2013

Last Update Submit

January 28, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference of treg and serum leptin levels among obese and normal weight individuals with and without asthma.

    3 years

Study Arms (4)

obese asthmatic

Participants from this group will be included in this study. A blood draw, breathing test will be performed to see if there is a difference in the t-regulatory cells amongst this group.

Biological: blood draw, breathing test

normal asthmatic

Participants from this group will be included in this study. A blood draw, breathing test will be performed to see if there is a difference in the t-regulatory cells amongst this group

Biological: blood draw, breathing test

obese control

Participants from this group will be included in this study. A blood draw, breathing test will be performed to see if there is a difference in the t-regulatory cells amongst this group.

Biological: blood draw, breathing test

normal control

Participants from this group will be included in this study. A blood draw, breathing test will be performed to see if there is a difference in the t-regulatory cells amongst this group.

Biological: blood draw, breathing test

Interventions

A blood draw,breathing test will be performed on every participant

normal asthmaticnormal controlobese asthmaticobese control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Females in good health between the ages of 18-50, with or without asthma.

You may qualify if:

  • Obese asthmatics
  • Normal weight asthmatics
  • Healthy obese
  • Health non-obese
  • Asthmatic subjects will be recruited:
  • If they have a physician diagnosis of adult onset asthma (asthma diagnosed after the age of 18).
  • If they have stable disease without exacerbation, physician or emergency department visits, or change in asthma medication for the past 4 weeks, inhaled steroids will be allowed.
  • Non asthmatic subjects
  • Will not have had a prior diagnosis of asthma,
  • Have no history of atopy.
  • Have no history of lung diseases.

You may not qualify if:

  • \> 10 pack year smoking history, or currently smoking
  • Pulmonary disease other than asthma.
  • History of heart disease
  • Weight loss greater than 10 kg, or greater than 10% initial body weight within the past 3 months.
  • Any agents that could potentially alter the inflammatory system such as thiazolidinedione, a statin, or oral steroid therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Shore LIJ Health System

New Hyde Park, New York, 11040, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

T regulatory cells are isolated in the blood specimens

MeSH Terms

Conditions

Asthma

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Rubin Cohen, MD

    North Shore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2013

First Posted

October 12, 2015

Study Start

May 1, 2011

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

January 29, 2016

Record last verified: 2016-01

Locations